Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the PrepQuant™ System, a novel sample preparation platform that ...
Invivoscribe launched the PrepQuant ™ sample preparation platform that integrates nucleic acid extraction, concentration, and quantification with a single automated instrument. The product is designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results